Iridex (IRIX) Income from Discontinued Operations (2011 - 2012)
Iridex (IRIX) posted Income from Discontinued Operations of -$160000.0 for Q4 2012, up 15.79% on a QoQ basis from -$190000.0 in Q3 2012, and down 532.43% year-over-year from $37000.0 in Q4 2011.
Powered by 
Analysis
Iridex (IRIX) Income from Discontinued Operations (2011 - 2012) Analysis & Trends
Iridex has reported Income from Discontinued Operations for 2 years, with the latest figure at -$160000.0 in Q4 2012.
- On a quarterly basis, Income from Discontinued Operations fell 532.43% year-over-year to -$160000.0 in Q4 2012; TTM through Sep 2013 was -$160000.0, a 108.8% decrease from a year earlier, with the FY2012 full-year figure at $1.9 million, up 186.68% from the prior year.
- Income from Discontinued Operations was -$160000.0 for Q4 2012 at Iridex, up from -$190000.0 in the prior quarter.
- The five-year high for Income from Discontinued Operations was $2.0 million in Q1 2012, with the low at -$190000.0 in Q3 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | - |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | - |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | - |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | - |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | - |
| 10 | Iridex | 12.22 Mn | 7.54 Mn | 4.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 29, 2012 | -160,000.00 |
| Sep 29, 2012 | -190,000.00 |
| Jun 30, 2012 | -61,000.00 |
| Mar 31, 2012 | 2.03 Mn |
| Dec 31, 2011 | 37,000.00 |
| Oct 1, 2011 | 177,000.00 |
| Jul 2, 2011 | 39,000.00 |
| Apr 2, 2011 | 381,000.00 |